August 20, 2012 / 10:26 PM / 7 years ago

Medtronic gets European nod for Viva/Brava heart device

Aug 20 (Reuters) - Medtronic Inc said it received European approval for its Viva/Brava portfolio of devices that is used on heart failure patients.

The world’s largest maker of medical devices said the products feature a new algorithm, called AdaptivCRTR, that maintains the patients’ normal heart rhythms.

Shares of the Minneapolis-based company closed at $41.45 on New York Stock Exchange on Monday.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below